4.7 Article

Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 209, 期 5, 页码 975-986

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20112457

关键词

-

资金

  1. National Institutes of Health [NS053488]
  2. Picower Foundation
  3. Benaroya Foundation
  4. Jeff and Anne Keefer Fund
  5. Stein-Bellet Family Fund
  6. University of Pennsylvania Institute for Translational Medicine and Therapeutics

向作者/读者索取更多资源

The accumulation of misfolded proteins is a fundamental pathogenic process in neuro-degenerative diseases. However, the factors that trigger aggregation of alpha-Synuclein (diseases. However, the factors that trigger aggregation of alpha-Synuclein (alpha-Syn), the principal component of the intraneuronal inclusions known as Lewy bodies (LBs), and Lewy neurites (LNs), which characterize Parkinson's disease (PD) and dementia with LBs (DLB), are poorly understood. We show here that in young asymptomatic alpha-Syn transgenic (Tg) mice, intracerebral injections of brain homogenates derived from older Tg mice exhibiting alpha-Syn pathology accelerate both the formation of intracellular LB/LN-like inclusions and the onset of neurological symptoms in recipient animals. Pathological alpha-Syn propagated along major central nervous system (CNS) pathways to regions far beyond injection sites and reduced survival with a highly reproducible interval from injection to death in inoculated animals. Importantly, inoculation with alpha-Syn amyloid fibrils assembled from recombinant human alpha-Syn induced identical consequences. Furthermore, we show for the first time that synthetic alpha-Syn fibrils are wholly sufficient to initiate PD-like LBs/LNs and to transmit disease in vivo. Thus, our data point to a prion-like cascade in synucleinopathies whereby cell-cell transmission and propagation of misfolded alpha-Syn underlie the CNS spread of LBs/LNs. These findings open up new avenues for understanding the progression of PD and for developing novel therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据